Cardiff Oncology (CRDF) Revenue (2011 - 2026)
Cardiff Oncology (CRDF) posted Revenue of $243000.0 for Q4 2025, up 102.5% sequentially from $120000.0 in Q3 2025, and up 60.93% YoY from $151000.0 in Q4 2024.
Cardiff Oncology (CRDF) Revenue (2011 - 2026) Analysis & Trends
Cardiff Oncology has reported Revenue for 15 years, with the latest figure at $243000.0 in Q4 2025.
- Quarterly Revenue rose 60.93% year-over-year to $243000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $593000.0 (down 13.3% YoY) and the FY2025 annual result came in at $593000.0, down 13.18% from the prior year.
- Revenue grew to $243000.0 in Q4 2025 per CRDF's latest filing, from $120000.0 in the prior quarter.
- Over five years, Revenue peaked at $243000.0 in Q4 2025 and troughed at $68000.0 in Q2 2021.
- A 5-year average of $125500.0 and a median of $120500.0 in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue surged 146.99% in 2024, then plunged 46.83% in 2025.
- Over 5 years, Revenue stood at $133000.0 in 2021, then dropped by 3.76% to $128000.0 in 2022, then climbed by 21.88% to $156000.0 in 2023, then decreased by 3.21% to $151000.0 in 2024, then jumped by 60.93% to $243000.0 in 2025.
- According to Business Quant data, Revenue over the past three periods registered $243000.0, $120000.0, and $121000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - | 104,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104,000.00 |
| Dec 31, 2025 | 243,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 121,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 205,000.00 |
| Dec 31, 2023 | 156,000.00 |
| Sep 30, 2023 | 141,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Dec 31, 2022 | 128,000.00 |
| Sep 30, 2022 | 93,000.00 |
| Jun 30, 2022 | 91,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 133,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Jun 30, 2021 | 68,000.00 |